Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Biotech
Vedana surfaces with $46M to develop migraine prevention therapies
Vedana has emerged from stealth with $46 million in series A financing aimed at advancing next-gen antibodies for migraine prevention.
Will Maddox
Jun 17, 2026 9:48am
New biotech Slate aims to solve migraine injection equation
Feb 24, 2026 7:30am
Lundbeck’s preventative migraine IV sees success in ph. 2
Feb 12, 2026 1:25pm
Salvia BioElectronics nets $60M for migraine neuromod implant
May 29, 2025 11:00am
FDA clears prescription migraine app from Click Therapeutics
Apr 17, 2025 11:35am
Lundbeck ends subcutaneous migraine cohort after futility review
Apr 1, 2025 5:00am
